Overview Request Sample Pages Request Customization Download PDF
You are viewing: UK Autoimmunity Diagnostics Market analysis

The UK Autoimmunity Diagnostics Market was valued at $577.7 Million in 2025 and projected to reach to $942.3 Million by 2030, representing a compound annual growth rate of 8.5%. The UK autoimmunity diagnostics market is positioned for sustained growth through 2030, driven by rising autoimmune disease prevalence and NHS modernization efforts.

UK Autoimmunity Diagnostics Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

UK Autoimmunity Diagnostics Market Trends and Insights

  • The UK market is driven by rising prevalence of autoimmune disorders, increased healthcare spending, and growing adoption of advanced diagnostic technologies across NHS and private healthcare facilities.
  • The UK's strong regulatory framework and emphasis on early disease detection position the country as a key market for innovative autoimmunity diagnostic solutions. In the UK, the shift toward personalized medicine and point-of-care testing is accelerating market growth between 2025 and 2030.
  • The UK healthcare system's focus on improving diagnostic accuracy and reducing time-to-diagnosis is spurring investment in multiplex testing platforms and biomarker-driven approaches.
  • Additionally, the UK's aging population and rising awareness of autoimmune conditions among both clinicians and patients are expected to sustain demand for comprehensive diagnostic services throughout the forecast period..

Key Market Statistics

  • CAGR (2025-2030) 8.5% CAGR
  • Market Size, 2025 ~USD 577.7 Million
  • Forecast, 2030 ~USD 942.3 Million
  • Country UK

UK Autoimmunity Diagnostics Market Overview

Market Valuation :

The UK autoimmunity diagnostics market is valued at $577.7 million in 2025 and is projected to reach $942.3 million by 2030, demonstrating strong growth potential in the region.

NHS Integration & Adoption :

Widespread adoption of advanced diagnostic technologies across NHS facilities and private healthcare providers is accelerating market expansion, with increased investment in laboratory infrastructure and automation.

Rising Disease Prevalence :

The UK is experiencing increased prevalence of autoimmune disorders including rheumatoid arthritis, lupus, and celiac disease, driving demand for early detection and accurate diagnostic solutions.

Healthcare Spending Growth :

Increased UK healthcare spending and government initiatives to improve diagnostic accuracy and patient outcomes are supporting market growth and innovation in autoimmunity testing platforms.

UK Autoimmunity Diagnostics Market Dynamics

  • Healthcare providers are increasingly investing in multiplex testing platforms and point-of-care diagnostics to improve patient outcomes and reduce diagnostic timelines.
  • The integration of artificial intelligence and digital pathology solutions is enhancing test accuracy and efficiency across UK laboratories.
  • Regulatory support and reimbursement policies continue to favor advanced diagnostic adoption, creating opportunities for both established and emerging diagnostic companies in the region..

Related Ecosystem

Analytical And Scientific Instrumentation

Top Technologies
  • Environmental Testing
  • Gas Chromatography
  • Polymerase Chain Reaction (PCR)
  • Automated Liquid Handling Systems
  • Flow Cytometry
Top Companies
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Agilent Technologies, Inc.
  • Merck KGaA
  • Shimadzu Corporation

    In Vitro Diagnostics

    Top Technologies
    • Polymerase Chain Reaction (PCR)
    • Enzyme-Linked Immunosorbent Assay (ELISA)
    • Dna Microarrays
    • Assay Kits
    • Microarrays
    Top Companies
    • ROCHE HOLDINGS AG
    • Thermo Fisher Scientific Inc.
    • Danaher Corporation
    • Abbott Laboratories
    • Biomerieux s.a.

      Key Takeaways

      • The UK autoimmunity diagnostics market will grow from $577.7M (2025) to $942.3M (2030) at an 8.5% CAGR.
      • The UK's NHS infrastructure and emphasis on early diagnosis are key drivers of market expansion.
      • Point-of-care testing and multiplex diagnostic platforms are gaining traction across UK healthcare settings.
      • The UK's aging population and rising autoimmune disease prevalence will sustain long-term market demand.

      Autoimmunity Diagnostics Market Report Scope

      Report Metric Details
      Base Year 2025
      Fastest Growing Segment AUTOANTIBODIES AND IMMUNOLOGIC TESTS (Test Type)
      Forecast Period 2025-2030
      Growth Rate CAGR of 8.3% from 2025 to 2030
      Largest Segment CONSUMABLES (Product)
      Market Size Base Year (Billions) ~USD 5.57 (2025)
      Revenue Forecast (Billions) ~USD 8.29 (2030)
      Segments Covered Product, Test Type, Disease Type, Type, End User

      UK Autoimmunity Diagnostics Market Report Segmentation

      5 segment dimensions are covered across the global market.

      By Product

      • Consumables
      • Instruments

      By Test Type

      • Autoantibodies And Immunologic Tests
      • Inflammatory Tests
      • Other Tests
      • Routine Laboratory Tests
      • Urinalysis Tests

      By Disease Type

      • Organ-Specific Autoimmune Diseases
      • Systemic Autoimmune Diseases

      By Type

      • Celiac Disease
      • Inflammatory Bowel Disease
      • Multiple Sclerosis
      • Other Organ-Specific Autoimmune Diseases
      • Other Systemic Autoimmune Diseases
      • Psoriasis
      • Rheumatoid Arthritis
      • Systemic Lupus Erythematosus
      • Type-1 Diabetes

      By End User

      • Clinical Laboratories
      • Hospitals & Clinics
      • Other End Users

      UK: AUTOIMMUNITY DIAGNOSTICS MARKET, BY END USER,2023–2031

      Segment20232024202520262028202920302031CAGR (%)
      CLINICAL LABORATORIES249264.6283.3304.9359393.8435485.49.4
      HOSPITALS & CLINICS192.6202213.5226.9260.6282.4308.3339.98.1
      OTHER END USERS75.477.98184.794.1100.4107.81176.3
      TOTAL517.1544.5577.7616.4713.7776.5851.1942.38.5

      Target Audience

      • Diagnostic Device Manufacturers : In vitro diagnostics (IVD) companies seeking to expand or establish presence in the UK market need detailed insights on NHS procurement processes, competitive positioning, and regulatory pathways for autoimmunity testing platforms.
      • Healthcare Providers & NHS Trusts : Laboratory directors and NHS procurement teams require market data to evaluate diagnostic technology investments, benchmark performance metrics, and identify best-in-class solutions for autoimmune disease testing.
      • Private Healthcare Operators : Private hospital networks and independent diagnostic laboratories need market intelligence to optimize service offerings, identify growth opportunities, and make informed capital allocation decisions in the autoimmunity diagnostics space.
      • Investment & Strategy Consultants : Private equity firms, venture capital investors, and management consultants require comprehensive UK market analysis to evaluate investment opportunities, assess market attractiveness, and develop growth strategies for diagnostic companies.
      • Pharmaceutical & Biotech Companies : Pharma companies developing autoimmune therapeutics need diagnostic market insights to understand companion diagnostic opportunities, patient stratification needs, and potential partnerships with UK diagnostic providers.

      Reasons to Buy this Report

      • NHS Market Penetration Strategy : Understand the UK NHS procurement landscape, reimbursement pathways, and integration requirements to effectively position diagnostic solutions within the largest healthcare provider network in the region.
      • Competitive Landscape Analysis : Identify key competitors, market share distribution, and differentiation opportunities among UK-based and international diagnostic manufacturers operating in the autoimmunity segment.
      • Regional Growth Drivers : Analyze UK-specific factors including disease prevalence trends, healthcare spending patterns, regulatory environment, and technology adoption rates that influence market dynamics and investment decisions.
      • Private Healthcare Opportunities : Evaluate the growing private diagnostics sector in the UK, including private hospital networks and independent laboratories, to identify alternative revenue streams and partnership opportunities.
      • Regulatory & Reimbursement Insights : Access detailed information on UK regulatory requirements, NICE guidelines, and NHS reimbursement policies specific to autoimmunity diagnostics to ensure market-compliant product strategies.

      Frequently asked questions

      What is the current size of the UK autoimmunity diagnostics market?

      The UK autoimmunity diagnostics market is valued at $577.7 million in 2025.

      What is the projected market size for the UK by 2030?

      The UK autoimmunity diagnostics market is projected to reach $942.3 million by 2030.

      What is the growth rate of the UK autoimmunity diagnostics market?

      The UK market is expected to grow at a compound annual growth rate (CAGR) of 8.5% from 2025 to 2030.

      What are the main drivers of growth in the UK autoimmunity diagnostics market?

      Key drivers include rising autoimmune disease prevalence, increased NHS investment in diagnostics, adoption of advanced testing technologies, and growing patient awareness in the UK.

      Which diagnostic technologies are most relevant to the UK market?

      Point-of-care testing, multiplex assays, biomarker-driven diagnostics, and automated laboratory platforms are gaining significant adoption across UK healthcare facilities.

      RESEARCH METHODOLOGY

      The study involved estimating activities to determine the current size of the autoimmunity diagnostics market. Exhaustive secondary research was done to collect information on the autoimmunity diagnostics industry. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the autoimmunity diagnostics market.

      Secondary Research

      Various sources were utilized to gather information for this study in the secondary research process. These sources included company annual reports, press releases, and investor presentations; white papers; certified publications; articles by recognized authors; reputable websites; and information from regulatory bodies and databases, such as D&B Hoovers, Bloomberg Business, and Factiva.

      Primary Research

      In the primary research process, various sources from both the supply & demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, service providers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess prospects.

      The following is a breakdown of the primary respondents:

      Autoimmunity Diagnostics Market

      Note 1: Others include sales, marketing, and product managers.

      Note 2: Companies are classified into tiers based on their total revenues. As of 2024, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = < USD 10 million.

      To know about the assumptions considered for the study, download the pdf brochure

      COMPANY NAME DESIGNATION
      Abbott Laboratories (US) Product Specialist
      Thermo Fisher Scientific Inc. (US) Clinical Sales Specialist

      Market Size Estimation

      Both top-down and bottom-up approaches were used to estimate and validate the autoimmunity diagnostics market's total size. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

      • The key players in the industry were identified through extensive secondary research.
      • Primary and secondary research determined the revenues generated by leading players operating in the autoimmunity diagnostics market.
      • All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources.

      The research methodology used to estimate the market size includes the following:

      Autoimmunity Diagnostics Market

      Data Triangulation

      The total market was split into several segments after arriving at the overall market size by applying the abovementioned process. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

      Market Definition

      Autoimmune diseases are defined as a medical condition in which an individual's immune system produces antibodies that attack the body's normal tissues. autoimmunity diagnostics systematically identifies autoimmune disorders through clinical assessment and laboratory investigations to detect immune system dysfunction. This process typically involves routine laboratory testing, measurement of systemic inflammatory markers, detection of disease-specific autoantibodies, urinalysis, and other specialized immunologic assays.

      Stakeholders

      • Manufacturers & distributors of autoimmunity diagnostics products
      • Clinical laboratories
      • Hospitals
      • Research institutes
      • Government associations
      • Venture capitalists & investors

      Report Objectives

      • To define, describe, segment, and forecast the global autoimmunity diagnostics market, by product, test type, disease type, end user, and region
      • To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
      • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall autoimmunity diagnostics market
      • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
      • To forecast the size of the market segments with respect to five regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
      • To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
      • To track and analyze company developments such as product launches & approvals, partnerships, acquisitions, agreements, and other developments
      • To benchmark players within the market using the proprietary Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business and product excellence

       

      Get the Full Autoimmunity Diagnostics Market Report

      Full forecast, segment splits, and company analysis for all Autoimmunity Diagnostics Market.

      Download Sample Pages Buy Report

      METHODOLOGY

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      Cite this Research
      DMCA.com Protection Status